INTERNATIONAL JOURNAL OF OBESITY, cilt.31, ss.1119-1125, 2007 (SCI İndekslerine Giren Dergi)
Objectives: To investigate the role of serum apolipoprotein (apo) B levels in predicting metabolic syndrome (MS), hypertension, atherogenic dyslipidemia and type II diabetes.